{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:28:48Z","timestamp":1791523728566,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204288"],"award-info":[{"award-number":["82204288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2023MB036"],"award-info":[{"award-number":["ZR2023MB036"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science, Education and Industry Integration Technology Innovation Project","award":["2022PT117"],"award-info":[{"award-number":["2022PT117"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11095-025-03997-y","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T23:21:02Z","timestamp":1766445662000},"page":"529-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Polymorphism Control of Carbamazepine Based on Deep Eutectic Solvents"],"prefix":"10.1007","volume":"43","author":[{"given":"Xian","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-2513","authenticated-orcid":false,"given":"Shuai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"3997_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrd1280","volume":"3","author":"S Datta","year":"2004","unstructured":"Datta S, Grant DJW. Crystal structures of drugs: advances in determination, prediction and engineering. Nat Rev Drug Discov. 2004;3:42\u201357.","journal-title":"Nat Rev Drug Discov"},{"key":"3997_CR2","doi-asserted-by":"publisher","unstructured":"McCrone W. Physics and chemistry of the organic solid state, Wiley Interscience, New York, DOI (1965) 725\u2013776. https:\/\/doi.org\/10.1021\/ja01062a056.","DOI":"10.1021\/ja01062a056"},{"key":"3997_CR3","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1021\/cr400249d","volume":"114","author":"AJ Cruz Cabeza","year":"2014","unstructured":"Cruz Cabeza AJ, Bernstein J. Conformational polymorphism. Chem Rev. 2014;114:2170\u201391.","journal-title":"Chem Rev"},{"key":"3997_CR4","doi-asserted-by":"crossref","unstructured":"Mullin JW. 6-Crystal growth. Crystallization (4th edn). 2001;625:216\u201388.","DOI":"10.1016\/B978-075064833-2\/50008-5"},{"key":"3997_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.addr.2003.10.008","volume":"56","author":"D Singhal","year":"2004","unstructured":"Singhal D, Curatolo W. Drug polymorphism and dosage form design: a practical perspective. Adv Drug Deliv Rev. 2004;56:335\u201347.","journal-title":"Adv Drug Deliv Rev"},{"key":"3997_CR6","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.2174\/1381612824666180515155425","volume":"24","author":"Z Yanan","year":"2018","unstructured":"Yanan Z, Jingkang W, Yan X, Ting W, Xin H. The effects of polymorphism on physicochemical properties and pharmacodynamics of solid drugs. Curr Pharm Des. 2018;24:2375\u201382.","journal-title":"Curr Pharm Des"},{"key":"3997_CR7","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1021\/cg050508j","volume":"6","author":"M M\u00fcller","year":"2006","unstructured":"M\u00fcller M, Meier U, Wieckhusen D, Beck R, Pfeffer-Hennig S, Schneeberger R. Process development strategy to ascertain reproducible API polymorph manufacture. Cryst Growth Des. 2006;6:946\u201354.","journal-title":"Cryst Growth Des"},{"key":"3997_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(01)00097-7","volume":"48","author":"SR Vippagunta","year":"2001","unstructured":"Vippagunta SR, Brittain HG, Grant DJW. Crystalline solids. Adv Drug Deliv Rev. 2001;48:3\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"3997_CR9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.xphs.2023.02.019","volume":"112","author":"J Iyer","year":"2023","unstructured":"Iyer J, Brunsteiner M, Modhave D, Paudel A. Role of crystal disorder and mechanoactivation in solid-state stability of pharmaceuticals. J Pharm Sci. 2023;112:1539\u201365.","journal-title":"J Pharm Sci"},{"key":"3997_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1023\/A:1025409608944","volume":"73","author":"R Hilfiker","year":"2003","unstructured":"Hilfiker R, Berghausen J, Blatter F, Burkhard A, De Paul SM, Freiermuth B, Geoffroy A, Hofmeier U, Marcolli C, Siebenhaar B, Szelagiewicz M, Vit A, von Raumer M. Polymorphism-ntegrated approach from high-throughput screening to crystallization optimization. J Therm Anal Calorim. 2003;73:429\u201340.","journal-title":"J Therm Anal Calorim"},{"key":"3997_CR11","doi-asserted-by":"publisher","first-page":"124189","DOI":"10.1016\/j.ijpharm.2024.124189","volume":"657","author":"ASC Leon","year":"2024","unstructured":"Leon ASC, Waterman KC, Wang G, Wang L, Cai T, Zhang X. Accelerated stability modeling of recrystallization from amorphous solid dispersions: a griseofulvin\/HPMC-AS case study. Int J Pharm. 2024;657:124189.","journal-title":"Int J Pharm"},{"key":"3997_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1021\/op000023y","volume":"4","author":"SR Chemburkar","year":"2000","unstructured":"Chemburkar SR, Bauer J, Deming K, Spiwek H, Patel K, Morris J, Henry R, Spanton S, Dziki W, Porter W, Quick J, Bauer P, Donaubauer J, Narayanan BA, Soldani M, Riley D, McFarland K. Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development. Org Process Res Dev. 2000;4:413\u20137.","journal-title":"Org Process Res Dev"},{"key":"3997_CR13","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1021\/acs.cgd.8b00765","volume":"18","author":"DH Case","year":"2018","unstructured":"Case DH, Srirambhatla VK, Guo R, Watson RE, Price LS, Polyzois H, Cockcroft JK, Florence AJ, Tocher DA, Price SL. Successful computationally directed templating of metastable pharmaceutical polymorphs. Cryst Growth Des. 2018;18:5322\u201331.","journal-title":"Cryst Growth Des"},{"key":"3997_CR14","doi-asserted-by":"publisher","first-page":"122530","DOI":"10.1016\/j.ijpharm.2022.122530","volume":"632","author":"H Qu","year":"2023","unstructured":"Qu H, Li Z, Wu S, Gong J. Mechanosynthesis of magnolol multicomponent crystalline solids for improved natural antibiotics and customizable release profiles. Int J Pharm. 2023;632:122530.","journal-title":"Int J Pharm"},{"key":"3997_CR15","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s11095-023-03532-x","volume":"40","author":"K Shi","year":"2023","unstructured":"Shi K, Li M. Optimisation of pharmaceutical cocrystal dissolution performance through a synergistic precipitation inhibition. Pharm Res. 2023;40:2051\u201369.","journal-title":"Pharm Res"},{"key":"3997_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-023-03618-6","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Huang X, Wang N, Wang T, Zhou L, Xu Z, Chen G, Cao W, Hao H. Hydration mechanism and its effect on the solubility of Aripiprazole. Pharm Res. 2024. https:\/\/doi.org\/10.1007\/s11095-023-03618-6.","journal-title":"Pharm Res"},{"key":"3997_CR17","doi-asserted-by":"publisher","unstructured":"Bao Chen SZ. Progress in research on the carbamazepine dosage forms. Int J Pharm Res. 2008;46\u201349+58. https:\/\/doi.org\/10.13220\/j.cnki.jipr.2008.01.035.","DOI":"10.13220\/j.cnki.jipr.2008.01.035"},{"key":"3997_CR18","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/jps.20647","volume":"95","author":"AJ Florence","year":"2006","unstructured":"Florence AJ, Johnston A, Price SL, Nowell H, Kennedy AR, Shankland N. An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine. J Pharm Sci. 2006;95:1918\u201330.","journal-title":"J Pharm Sci"},{"key":"3997_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijpharm.2007.06.053","volume":"348","author":"A Getsoian","year":"2008","unstructured":"Getsoian A, Lodaya RM, Blackburn AC. One-solvent polymorph screen of carbamazepine. Int J Pharm. 2008;348:3\u20139.","journal-title":"Int J Pharm"},{"key":"3997_CR20","doi-asserted-by":"publisher","first-page":"7074","DOI":"10.1039\/c1cc11634g","volume":"47","author":"JB Arlin","year":"2011","unstructured":"Arlin JB, Price LS, Price SL, Florence AJ. A strategy for producing predicted polymorphs: catemeric carbamazepine form V. Chem Commun. 2011;47:7074\u20136.","journal-title":"Chem Commun"},{"key":"3997_CR21","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.xphs.2017.03.045","volume":"106","author":"RA Halliwell","year":"2017","unstructured":"Halliwell RA, Bhardwaj RM, Brown CJ, Briggs NEB, Dunn J, Robertson J, Nordon A, Florence AJ. Spray drying as a reliable route to produce metastable carbamazepine form IV. J Pharm Sci. 2017;106:1874\u201380.","journal-title":"J Pharm Sci"},{"key":"3997_CR22","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1021\/cg301456m","volume":"13","author":"MA O\u2019Mahony","year":"2013","unstructured":"O\u2019Mahony MA, Seaton CC, Croker DM, Veesler S, Rasmuson \u00c5C, Hodnett BK. Investigation into the mechanism of solution-mediated transformation from form I to form III carbamazepine: the role of dissolution and the interaction between polymorph surfaces. Cryst Growth Des. 2013;13:1861\u201371.","journal-title":"Cryst Growth Des"},{"key":"3997_CR23","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1021\/cg3005689","volume":"12","author":"K Sypek","year":"2012","unstructured":"Sypek K, Burns IS, Florence AJ, Sefcik J. In situ monitoring of stirring effects on polymorphic transformations during cooling crystallization of carbamazepine. Cryst Growth Des. 2012;12:4821\u20138.","journal-title":"Cryst Growth Des"},{"key":"3997_CR24","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1021\/acs.cgd.0c00382","volume":"20","author":"R Prasad","year":"2020","unstructured":"Prasad R, Panwar K, Katla J, Dalvi SV. Polymorphism and particle formation pathway of carbamazepine during sonoprecipitation from ionic liquid solutions. Cryst Growth Des. 2020;20:5169\u201383.","journal-title":"Cryst Growth Des"},{"key":"3997_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1039\/D0CE01357A","volume":"23","author":"J Ouyang","year":"2021","unstructured":"Ouyang J, Chen J, Rosbottom I, Chen W, Guo M, Heng JYY. Supersaturation and solvent dependent nucleation of carbamazepine polymorphs during rapid cooling crystallization. CrystEngComm. 2021;23:813\u201323.","journal-title":"CrystEngComm"},{"key":"3997_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12247-017-9294-9","volume":"12","author":"S Patil","year":"2017","unstructured":"Patil S, Xalxo K, Mahadik K. Probing influence of solvent on polymorphic transformation of carbamazepine using electrospray technology. J Pharm Innov. 2017;12:309\u201318.","journal-title":"J Pharm Innov"},{"key":"3997_CR27","doi-asserted-by":"publisher","first-page":"126644","DOI":"10.1016\/j.jcrysgro.2022.126644","volume":"588","author":"K Zhao","year":"2022","unstructured":"Zhao K, Liu P, Li K, Zhang Y, Cao J, Cheng J, Yang C. Effect of polyethylene glycol additives on the polymorph and crystal habit of carbamazepine. J Cryst Growth. 2022;588:126644.","journal-title":"J Cryst Growth"},{"key":"3997_CR28","doi-asserted-by":"publisher","first-page":"7108","DOI":"10.1039\/c2cs35178a","volume":"41","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, De Oliveira Vigier K, Royer S, J\u00e9r\u00f4me F. Deep eutectic solvents: syntheses, properties and applications. Chem Soc Rev. 2012;41:7108\u201346.","journal-title":"Chem Soc Rev"},{"key":"3997_CR29","doi-asserted-by":"publisher","first-page":"18145","DOI":"10.1039\/C6CP02815B","volume":"18","author":"CR Ashworth","year":"2016","unstructured":"Ashworth CR, Matthews RP, Welton T, Hunt PA. Doubly ionic hydrogen bond interactions within the choline chloride-urea deep eutectic solvent. Phys Chem Chem Phys. 2016;18:18145\u201360.","journal-title":"Phys Chem Chem Phys"},{"key":"3997_CR30","doi-asserted-by":"publisher","unstructured":"Abbott AP, Capper G, Davies DL, Rasheed RK, Tambyrajah V. Novel solvent properties of choline chloride\/urea mixtures. Chem Commun. 2003;70\u201371.\u00a0https:\/\/doi.org\/10.1039\/B210714G.","DOI":"10.1039\/B210714G"},{"key":"3997_CR31","doi-asserted-by":"publisher","first-page":"14807","DOI":"10.1021\/acs.jmedchem.4c01550","volume":"67","author":"A Sharma","year":"2024","unstructured":"Sharma A, Park YR, Garg A, Lee BS. Deep eutectic solvents enhancing drug solubility and its delivery. J Med Chem. 2024;67:14807\u201319.","journal-title":"J Med Chem"},{"key":"3997_CR32","doi-asserted-by":"publisher","first-page":"2400090","DOI":"10.1002\/adtp.202400090","volume":"7","author":"D Dhiman","year":"2024","unstructured":"Dhiman D, Alhammadi M, Kim H, Umapathi R, Huh YS, Venkatesu P. Designer solvents for pharmaceutics: role of Ionic liquids \/ deep eutectic solvents in pharmaceutical formulations. Adv Ther. 2024;7:2400090.","journal-title":"Adv Ther"},{"key":"3997_CR33","doi-asserted-by":"publisher","first-page":"27631","DOI":"10.1021\/jp506957y","volume":"118","author":"MS Miran","year":"2014","unstructured":"Miran MS, Yasuda T, Susan MABH, Dokko K, Watanabe M. Binary protic ionic liquid mixtures as a proton conductor: high fuel cell reaction activity and facile proton transport. J Phys Chem C. 2014;118:27631\u20139.","journal-title":"J Phys Chem C"},{"key":"3997_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijpharm.2015.06.038","volume":"492","author":"IM Aroso","year":"2015","unstructured":"Aroso IM, Craveiro R, Rocha \u00c2, Dion\u00edsio M, Barreiros S, Reis RL, Paiva A, Duarte ARC. Design of controlled release systems for THEDES \u2014 therapeutic deep eutectic solvents, using supercritical fluid technology. Int J Pharm. 2015;492:73\u20139.","journal-title":"Int J Pharm"},{"key":"3997_CR35","doi-asserted-by":"publisher","first-page":"152032","DOI":"10.1016\/j.cej.2024.152032","volume":"491","author":"L Yang","year":"2024","unstructured":"Yang L, Zhang D, Lu D, Shi Y, Jia G, Wang S, Zhang K, Zhao K, Luan Y. Plant-derived exosome-like nanovesicles-created injectable hydrogel for augmented cancer immunotherapy. Chem Eng J. 2024;491:152032.","journal-title":"Chem Eng J"},{"key":"3997_CR36","doi-asserted-by":"publisher","first-page":"125006","DOI":"10.1016\/j.ijpharm.2024.125006","volume":"667","author":"Y Li","year":"2024","unstructured":"Li Y, Yu Q, Lu Y, He H, Qi J, Tai Z, Chen Z, Zhu Q, Wu W. Enhanced transdermal delivery of insulin by choline-based ionic liquids. Int J Pharm. 2024;667:125006.","journal-title":"Int J Pharm"},{"key":"3997_CR37","doi-asserted-by":"publisher","first-page":"107198","DOI":"10.1016\/j.ejps.2025.107198","volume":"212","author":"P \u00d6versti","year":"2025","unstructured":"\u00d6versti P, Han B, Kavakka J, Torssell S, Tirronen E, Louhi Kultanen M, Oinas P. The influence of solvent composition and process parameters on the particle properties of phytosterols in batch cooling crystallization. Eur J Pharm Sci. 2025;212:107198.","journal-title":"Eur J Pharm Sci"},{"key":"3997_CR38","doi-asserted-by":"publisher","first-page":"106956","DOI":"10.1016\/j.ejps.2024.106956","volume":"204","author":"P \u00d6versti","year":"2025","unstructured":"\u00d6versti P, Han B, Kavakka J, Torssell S, Tirronen E, Louhi Kultanen M, Oinas P. The effect of water on the crystallization of phytosterols and phytostanols in organic solutions. Eur J Pharm Sci. 2025;204:106956.","journal-title":"Eur J Pharm Sci"},{"key":"3997_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/jcht.1998.0424","volume":"31","author":"A Apelblat","year":"1999","unstructured":"Apelblat A, Manzurola E. Solubilities ofo-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic, andp-toluic acid, and magnesium-DL-aspartate in water from T = (278 to 348) K. J Chem Thermodyn. 1999;31:85\u201391.","journal-title":"J Chem Thermodyn"},{"key":"3997_CR40","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1021\/acs.jced.0c00513","volume":"65","author":"S Yu","year":"2020","unstructured":"Yu S, Xing W, Xue F, Cheng Y, Liu Y, Chen H, Hao C, Sun Y. Measurement and correlation of solubility and thermodynamic properties of fluoxetine hydrochloride in 15 pure solvents and a methanol + water binary solvent system. J Chem Eng Data. 2020;65:4656\u201368.","journal-title":"J Chem Eng Data"},{"key":"3997_CR41","doi-asserted-by":"publisher","first-page":"106301","DOI":"10.1016\/j.jct.2020.106301","volume":"153","author":"J Sha","year":"2021","unstructured":"Sha J, Ma T, Huang Z, Hu X, Zhang R, Cao Z, Wan Y, Sun R, He H, Jiang G, Li Y, Li T, Ren B. Solubility determination, model evaluation, Hansen solubility parameter and thermodynamic properties of benorilate in six pure solvents and two binary solvent mixtures. J Chem Thermodyn. 2021;153:106301.","journal-title":"J Chem Thermodyn"},{"key":"3997_CR42","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1021\/acs.jced.4c00300","volume":"69","author":"Y Mou","year":"2024","unstructured":"Mou Y, Pan Y, Pan Z, Wang Y, Wu Y, Fang S, Du S, Xue F. Determination and correlation of the solubility of D-psicose in 15 pure solvents at temperatures of 283.15 to 323.15 K. J Chem Eng Data. 2024;69:3217\u201325.","journal-title":"J Chem Eng Data"},{"key":"3997_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1380-7323(96)80044-6","volume":"3","author":"M Orozco","year":"1996","unstructured":"Orozco M, Luque FJ. Generalization of the molecular electrostatic potential for the study of noncovalent interactions. Theor Comput Chemistry. 1996;3:181\u2013218.","journal-title":"Theor Comput Chemistry"},{"key":"3997_CR44","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcc.22885","volume":"33","author":"T Lu","year":"2012","unstructured":"Lu T, Chen F. Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem. 2012;33:580\u201392.","journal-title":"J Comput Chem"},{"key":"3997_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14:33\u20138.","journal-title":"J Mol Graph"},{"key":"3997_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00894-016-2909-0","volume":"22","author":"H Sun","year":"2016","unstructured":"Sun H, Jin Z, Yang C, Akkermans RLC, Robertson SH, Spenley NA, Miller S, Todd SM. COMPASS II: extended coverage for polymer and drug-like molecule databases. J Mol Model. 2016;22:47.","journal-title":"J Mol Model"},{"key":"3997_CR47","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1039\/C9CE00908F","volume":"21","author":"C Hu","year":"2019","unstructured":"Hu C, Testa CJ, Shores BT, Wu W, Shvedova K, Born SC, Chattopadhyay S, Takizawa B, Mascia S. An experimental study on polymorph control and continuous heterogeneous crystallization of carbamazepine. CrystEngComm. 2019;21:5076\u201383.","journal-title":"CrystEngComm"},{"key":"3997_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejps.2017.05.013","volume":"105","author":"J Deng","year":"2017","unstructured":"Deng J, Staufenbiel S, Bodmeier R. Evaluation of a biphasic in vitro dissolution test for estimating the bioavailability of carbamazepine polymorphic forms. Eur J Pharm Sci. 2017;105:64\u201370.","journal-title":"Eur J Pharm Sci"},{"key":"3997_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.2042-7158.1994.tb03770.x","volume":"46","author":"Y Matsuda","year":"1994","unstructured":"Matsuda Y, Akazawa R, Teraoka R, Otsuka M. Pharmaceutical evaluation of carbamazepine modifications: comparative study for photostability of carbamazepine polymorphs by using fourier-transformed reflection-absorption infrared spectroscopy and colorimetric measurement. J Pharm Pharmacol. 1994;46:162\u20137.","journal-title":"J Pharm Pharmacol"},{"key":"3997_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jpba.2013.01.042","volume":"78-79","author":"R Caliandro","year":"2013","unstructured":"Caliandro R, Di Profio G, Nicolotti O. Multivariate analysis of quaternary carbamazepine-saccharin mixtures by X-ray diffraction and infrared spectroscopy. J Pharm Biomed Anal. 2013;78\u201379:269\u201379.","journal-title":"J Pharm Biomed Anal"},{"key":"3997_CR51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1021\/acs.oprd.7b00322","volume":"22","author":"D Acevedo","year":"2018","unstructured":"Acevedo D, Yang X, Mohammad A, Pavurala N, Wu WL, O\u2019Connor TF, Nagy ZK, Cruz CN. Raman spectroscopy for monitoring the continuous crystallization of carbamazepine. Org Process Res Dev. 2018;22:156\u201365.","journal-title":"Org Process Res Dev"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03997-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:01:44Z","timestamp":1772744504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03997-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3997"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03997-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}